- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Equine VEGF antibody and antigen (recombinant protein)
Diagnostic anti-Equine VEGF antibodies pairs and antigen for animal health (animal Equine/Horse angiogenesis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-EQU-VEGF-Ag01 | Equine VEGF | $3090.00 |
| GMP-EQU-VEGF-Ab01 | Anti-Equine VEGF mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-VEGF-Ab02 | Anti-Equine VEGF mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-VEGF-Ab03 | Anti-Equine VEGF human monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-VEGF-Ab04 | Anti-Equine VEGF human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-EQU-VEGF-Ag01 |
| Product Name | Equine VEGF |
| Target/Biomarker | Equine VEGF |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Equine VEGF antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VEGF level test of animal Equine/Horse with angiogenesis. |
| Tag | His | Reconized/Reactive Specics | Equine VEGF |
| Product description | Recombinant Equine VEGF protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-VEGF-Ab01,GMP-EQU-VEGF-Ab02 |
| Target/Biomarker | Equine VEGF |
| Product Name | Anti-Equine VEGF mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Equine VEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VEGF antibodies in Equine VEGF level test of animal Equine/Horse with angiogenesis. |
| Product description | Anti-Equine VEGF mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VEGF antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-VEGF-Ab03,GMP-EQU-VEGF-Ab04 |
| Target/Biomarker | Equine VEGF |
| Product Name | Anti-Equine VEGF human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Equine VEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VEGF antibodies in Equine VEGF level test of animal Equine/Horse with angiogenesis. |
| Product description | Anti-Equine VEGF mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Equine Vascular Endothelial Growth Factor (eVEGF) occupies a pivotal position in the intricate web of equine physiology, serving as a guardian of vascular health and orchestrator of angiogenesis—the creation of new blood vessels from existing ones. Encoded by the VEGF-A gene, eVEGF comes in several isoforms, each meticulously designed to engage with specific receptors, ensuring precise control over angiogenesis in horses.
At its core, eVEGF is a glycoprotein primarily expressed in endothelial cells, which line the inner walls of blood vessels. Its primary mission is to initiate and regulate angiogenesis—a dynamic and finely-tuned process that plays a critical role in various aspects of equine life. During embryonic development, eVEGF steers the formation of the intricate vascular network required to nourish the developing equine fetus. In adulthood, it remains an unwavering ally, promoting the growth of new blood vessels at the site of injuries, ensuring efficient tissue repair. Additionally, eVEGF plays a pivotal role in maintaining proper vascularization of the uterus during equine pregnancies, providing a nurturing environment for the developing foal.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
